These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


225 related items for PubMed ID: 29426481

  • 21. Drug repurposing for the treatment of alveolar echinococcosis: in vitro and in vivo effects of silica nanoparticles modified with dichlorophen.
    Fabbri J, Pensel PE, Albani CM, Arce VB, Mártire DO, Elissondo MC.
    Parasitology; 2019 Nov; 146(13):1620-1630. PubMed ID: 31397256
    [Abstract] [Full Text] [Related]

  • 22. Efficacy of osthole for Echinococcus granulosus in vitro and Echinococcus multilocularis in vivo.
    Yuan M, Luo Y, Xin Q, Gao H, Zhang G, Jing T.
    Vet Parasitol; 2016 Aug 15; 226():38-43. PubMed ID: 27514881
    [Abstract] [Full Text] [Related]

  • 23. Secondary and primary murine alveolar echinococcosis: combined albendazole/nitazoxanide chemotherapy exhibits profound anti-parasitic activity.
    Stettler M, Rossignol JF, Fink R, Walker M, Gottstein B, Merli M, Theurillat R, Thormann W, Dricot E, Segers R, Hemphill A.
    Int J Parasitol; 2004 Apr 15; 34(5):615-24. PubMed ID: 15064126
    [Abstract] [Full Text] [Related]

  • 24. 2-Deoxy-D-glucose and combined 2-Deoxy-D-glucose/albendazole exhibit therapeutic efficacy against Echinococcus granulosus protoscoleces and experimental alveolar echinococcosis.
    Xin Q, Lv W, Xu Y, Luo Y, Zhao C, Wang B, Yuan M, Li H, Song X, Jing T.
    PLoS Negl Trop Dis; 2022 Jul 15; 16(7):e0010618. PubMed ID: 35849619
    [Abstract] [Full Text] [Related]

  • 25. [Efficacy of albendazole chitosan microspheres against Echinococcus granulosus infection in mice].
    Liang W, Wang XC, Wu XW, Zhang SJ, Sun H, Ma X, Peng XY.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2014 Jun 15; 32(3):188-92. PubMed ID: 25223052
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. A preventive effect of the combination of albendazole and pomegranate peel aqueous extract treatment in cystic echinococcosis mice model: An alternative approach.
    Labsi M, Soufli I, Khelifi L, Amir ZC, Touil-Boukoffa C.
    Acta Trop; 2019 Sep 15; 197():105050. PubMed ID: 31170379
    [Abstract] [Full Text] [Related]

  • 28. Improvement of Antialveolar Echinococcosis Efficacy of Albendazole by a Novel Nanocrystalline Formulation with Enhanced Oral Bioavailability.
    Hu C, Liu Z, Liu C, Zhang Y, Fan H, Qian F.
    ACS Infect Dis; 2020 May 08; 6(5):802-810. PubMed ID: 31576751
    [Abstract] [Full Text] [Related]

  • 29. In vivo evaluation of the efficacy of combined albedazole-IFN-α treatment for cystic echinococcosis in mice.
    Zhang S, Zhou Y, Su L, Zhang X, Wang H, Liu B.
    Parasitol Res; 2017 Feb 08; 116(2):735-742. PubMed ID: 27928681
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. In Vitro and in Vivo Effect of MAPK Signal Transduction Pathway Inhibitors on Echinococcus multilocularis.
    Gui WF, Xu S, Dang ZS, Zhao YM.
    J Parasitol; 2019 Feb 08; 105(1):146-154. PubMed ID: 30807708
    [Abstract] [Full Text] [Related]

  • 33. Metformin improves the therapeutic efficacy of low-dose albendazole against experimental alveolar echinococcosis.
    Loos JA, Coccimiglio M, Nicolao MC, Rodrigues CR, Cumino AC.
    Parasitology; 2022 Jan 08; 149(1):138-144. PubMed ID: 35184788
    [Abstract] [Full Text] [Related]

  • 34. Could ivermectin have a synergic effect with albendazole in hydatidosis therapy?
    Moreno MJ, Casado N, Urrea-París MA, Rodríguez-Caabeiro F.
    Parasitol Res; 2002 Jun 08; 88(6):563-7. PubMed ID: 12107480
    [Abstract] [Full Text] [Related]

  • 35. The combination of carvacrol and albendazole enhanced the efficacy of monotherapy in experimental alveolar echinococcosis.
    Lopez LM, Pensel PE, Fabbri J, Albani CM, Elissondo N, Gambino G, Elissondo MC.
    Acta Trop; 2022 Jan 08; 225():106198. PubMed ID: 34688631
    [Abstract] [Full Text] [Related]

  • 36. In vivo and in vitro efficacy of crocin against Echinococcus multilocularis.
    Liu C, Fan H, Guan L, Ge RL, Ma L.
    Parasit Vectors; 2021 Jul 13; 14(1):364. PubMed ID: 34256821
    [Abstract] [Full Text] [Related]

  • 37. In vitro and in vivo effects of chitosan-praziquantel and chitosan-albendazole nanoparticles on Echinococcus granulosus Metacestodes.
    Torabi N, Dobakhti F, Faghihzadeh S, Haniloo A.
    Parasitol Res; 2018 Jul 13; 117(7):2015-2023. PubMed ID: 29616349
    [Abstract] [Full Text] [Related]

  • 38. Immune response of mice with alveolar echinococcosis to therapy with transfer factor, alone and in combination with albendazole.
    Dvoroznáková E, Porubcová J, Sevcíková Z.
    Parasitol Res; 2009 Oct 13; 105(4):1067-76. PubMed ID: 19548004
    [Abstract] [Full Text] [Related]

  • 39. Albendazole chemotherapy for human cystic and alveolar echinococcosis in north-western China.
    Wen H, Zou PF, Yang WG, Lu J, Wang YH, Zhang JH, New RR, Craig PS.
    Trans R Soc Trop Med Hyg; 1994 Oct 13; 88(3):340-3. PubMed ID: 7974683
    [Abstract] [Full Text] [Related]

  • 40. Praziquantel and albendazole in the combined treatment of experimental hydatid disease.
    Moreno MJ, Urrea-París MA, Casado N, Rodriguez-Caabeiro F.
    Parasitol Res; 2001 Mar 13; 87(3):235-8. PubMed ID: 11293572
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.